Table of Contents What Cagrilintide and Retatrutide Are and How They Work Approved Uses and Current Clinical Evidence in the UK How These Medicines May Affect Men Specifically Dosage, Administration, and What to Expect Side Effects, Risks, and Safety Considerations Availability on the NHS and Next Steps for Treatment Scientific References Frequently Asked Questions What Cagrilintide and Retatrutide Are and How They Work Cagrilintide is a long-acting amylin analogue that promotes satiety and slows gastric emptying, while retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors to reduce appetite, enhance insulin secretion, and increase energy expenditure
It combines essential vitamins, minerals, and antioxidants in balanced doses, without unnecessary fillers
Always consult a healthcare provider before starting injections
Removal from Category 2 does not automatically grant Category 1 status
Many people find that maintaining high levels of glutathione supports a shift toward the production of pheomelanin rather than eumelanin
Some users run 8-12 week injectable courses and bridge with oral precursors (NAC or liposomal glutathione) during off periods, though this appears to be a cost management strategy rather than a physiological requirement
